Sex differences in ibogaine antagonism of morphine-induced locomotor activity and in ibogaine brain levels and metabolism

Pharmacology Biochemistry and Behavior

Volumn 57, Issue 4, 1997, Pages 809-815

  Pearl, S M ^b   Hough, L B ^a   Boyd, D L ^a   Glick, S D ^a  

^a ALBANY MEDICAL COLLEGE   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Ibogaine; Locomotor activity; Morphine; Noribogaine; Route of administration; Sex differences

Indexed keywords

DRUG METABOLITE; IBOGAINE; MORPHINE; NORIBOGAINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG BRAIN LEVEL; DRUG METABOLISM; FEMALE; GAS CHROMATOGRAPHY; INTRAPERITONEAL DRUG ADMINISTRATION; LOCOMOTION; MALE; MASS SPECTROMETRY; NONHUMAN; PRIORITY JOURNAL; RAT; SEX DIFFERENCE; SUBCUTANEOUS DRUG ADMINISTRATION;

ANIMALS; BRAIN; DRUG ANTAGONISM; FEMALE; HALLUCINOGENS; IBOGAINE; INJECTIONS, INTRAPERITONEAL; INJECTIONS, SUBCUTANEOUS; MALE; MORPHINE; MOTOR ACTIVITY; NARCOTICS; RATS; RATS, SPRAGUE-DAWLEY; SEX FACTORS; TIME FACTORS;

ANIMALIA;

EID: 0030796645     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-3057(96)00383-8     Document Type: Article

References (24)

1. Bandiera, S.; Ryan, D. E.; Levin, W.; Thomas, P. E.: Age- and sex-related expression of cytochrome P450f and P450g in rat liver. Arch. Biochem. Biophys. 248:658-676; 1986.
2. Cappendijk, S. L. T.; Dzoljic, M. R.: Inhibitory effects of ibogaine on cocaine self-administration in rats. Eur. J. Pharmacol. 241:261-265; 1993.
3. Deecher, D. C.; Teitler, M.; Soderlund, D. M.; Bornmann, W. G.; Keuhne, M. E.; Glick, S. D.: Mechanism of action of ibogaine and harmaline congeners based on radioligand binding studies. Brain Res. 571:242-247; 1992.
4. Gallagher, C. A.; Hough, L. B.; Keefner, S. M.; Seyed Mozaffari, A.; Archer, S.; Glick, S. D.: Identification and quantification of the indole alkaloid ibogaine in biological samples by gas chromatography-mass spectrometry. Biochem. Pharmacol. 49:73-79; 1995.
5. Glick, S. D.; Rossman, K.; Steindorf, S.; Maisonneuve, I. M.; Carlson, J. N.: Effects and aftereffects of ibogaine on morphine self-administration in rats. Eur. J. Pharmacol. 195:341-345; 1991.
6. Glick, S. D.; Gallagher, C. A.; Hough, L. B.; Rossman, K. L.; Maisonneuve, I. M.: Differential effects of ibogaine pretreatment on brain levels of morphine and (+)-amphetamine. Brain Res. 558:173-176; 1992.
7. Glick, S. D.; Keuhne, M. E.; Raucci, J.; Wilson, T. E.; Larson, D.; Keller, R. W. Jr; Carlson, J. N.: Effects of iboga alkaloids on morphine and cocaine self-administration in rats: relationship to tremorigenic effects and to effects on dopamine release in nucleus accumbens and striatum. Brain Res. 657:14-22; 1994.
8. Glick, S. D.; Maisonneuve, I. M.; Pearl, S. M.: Mechanism of action of ibogaine: interaction between kappa agonist and NMDA antagonist effects. College on Problems of Drug Dependence Annual Meeting; 1996.
9. Glick, S. D.; Pearl, S. M.; Cai, Z.; Maisonneuve, I. M.: Ibogaine-like effects of noribogaine in rats. Brain Res 713:294-297; 1996.
10. Henderson, C. J.; Scott, A. R.; Yang, C. S.; Wolf, C. R.: Testosterone-mediated regulation of mouse renal cytochrome P-450 isoenzymes. Biochem. J. 266:675-681; 1990.
11. Hough, L. B.; Pearl, S. M.; Glick, S. D.: Tissue distribution of ibogaine after intraperitoneal and subcutaneous administration. Life Sci. 58:119-122; 1995.
12. 3H]Ibogaine in the rat. College on Problems of Drug Dependence Annual Meeting; 1993.
13. Joyce, E. M.; Iversen, S. D.: The effect of morphine applied locally to mesencephalic dopamine cell bodies on spontaneous motor activity in mice. Neurosci. Lett. 14:207-212; 1979.
14. Maisonneuve, I. M.; Keller, R. W. Jr.; Glick, S. D.: Interactions between ibogaine, a potential antiaddictive agent, and morphine: an in vivo microdialysis study. Eur. J. Pharmacol. 199:35-42; 1991.
15. Maisonneuve, I. M.; Rossman, K. L.; Keller, R. W. Jr; Glick, S. D.: Acute and prolonged effects of ibogaine on brain dopamine metabolism and morphine-induced locomotor activity in rats. Brain Res. 575:69-73; 1992.
16. Mash, D. C.; Staley, J. K.; Baumann, M. H.; Rothman, R. B.; Hearn, W. L.: Identification of a primary metabolite of ibogaine that targets serotonin transporters and elevates serotonin. Life Sci. 57:45-50; 1995.
17. Mash, D. C.; Staley, J. K.; Pablo, J. P.; Holohean, A. M.; Hackman, J. C.; Davidoff, R. A.: Properties of ibogaine and its prinicipal metabolite (12-hydroxyibogamine) at the MK-801 binding site of the NMDA receptor complex. Neurosci. Lett. 192:53-56; 1995.
18. Pearl, S. M.; Herrick-Davis, K.; Teitler, M.; Glick, S. D.: Radioligand binding study of noribogaine, a likely metabolite of ibogaine. Brain Res. 675:342-344; 1995.
19. Pearl, S. M.; Johnson, D. W. Glick, S. D.: Prior morphine enhances ibogaine antagonism of morphine-induced locomotor stimulation. Psychopharmacology 121:470-475; 1995.
20. 3H]MK-801 binding to the NMDA receptor complex. Psychopharamcology 114:672-674; 1994.
21. Popik, P.; Layer, R. T.; Fossom, L. H.; Beneviste, M.; Geter-Douglass, B.; Witkin, J. W.; Skolnick, P.: NMDA antagonist properties of the putative antiaddictive drug, ibogaine. J. Pharmacol. Exp. Ther. 275:753-760; 1995.
22. Repke, D. B.; Artis, D. R.; Nelson, J. T.; Wong, E. H. F.: Abbreviated ibogaine congeners. Synthesis and reactions of tropan3-yl-2- and 3-indoles. Investigation of an unusual isomerization of 2-substituted indoles using computational and spectrscopic techniques. J. Org. Chem. 59:2164-2171; 1994.
23. Shapiro, B. H.; Pampori, N. A.; Lapenson, D. P.; Waxman, D. J.: Growth hormone-dependent and -independent sexually dimorphic regulation of phenobarbital-induced hepatic cytochromes P450 2B1 and 2B2. Arch. Biochem. Biophys. 312:234-239; 1994.
24. Sweetnam, P. M.; Lancaster, J.; Snowman, A.; Collins, J. L.; Perschke, S.; Bauer, C.; Ferkany, J.: Receptor binding profile suggests multiple mechanisms of action are responsible for ibogaine's putative anti-addictive activity. Psychopharamacology 118:369-376; 1995.